Accéder au contenu
Merck
  • The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.

The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.

The Biochemical journal (2014-07-17)
Marina A Guvakova, William S Y Lee, Dana K Furstenau, Indira Prabakaran, David C Li, Rupert Hung, Natasha Kushnir
RÉSUMÉ

The Ras-related GTPase Rap1 promotes cell adhesion and migration. Although the significance of Rap1 contribution to cell migration is increasingly being recognized, little is known about the biochemical mechanisms driving this process. In the present study, we discovered a previously unidentified regulatory role of insulin-like growth factor type I (IGF-I) receptor (IGF-IR) in CRK Src homology 3 (SH3)-binding guanine-nucleotide-releasing protein (C3G)-Rap1-fascin-actin axis promoting cell movement. We demonstrate that a burst of Rap1 activity, rather than presumed hyperactivation, is imperative for the onset of cell movement. We show that while autophosphorylated IGF-IR signals to C3G to activate Rap1, subsequent IGF-IR internalization promotes gradual inactivation of Rap1 by putative Rap1 GTPase-activating protein (GAP). Additionally, IGF-IR signalling recruits active Rap1 at sites of cell motile protrusions. C3G depletion prevents IGF-I-induced fascin accumulation at actin microspikes and blocks protrusions. In the absence of IGF-IR activity, the wild-type (WT) Rap1 and the constitutively active V12Rap1 mutant remain in cell-cell contacts. Forced inactivation of Rap1 signalling by overexpressing dominant negative N17Rap1, Rap1GAP or by silencing C3G has a detrimental effect on filamentous (F)-actin and cell adhesion irrespective of IGF-IR signalling. We conclude that the basal levels of Rap1 activity holds up cell adhesion, whereas sequential regulation of C3G and GAP by IGF-IR reverses the labile Rap1 function from supporting adhesion to promoting migration.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Diméthylsulfoxyde, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Diméthylsulfoxyde, ACS reagent, ≥99.9%
Sigma-Aldrich
Diméthylsulfoxyde, for molecular biology
Sigma-Aldrich
Diméthylsulfoxyde, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Diméthylsulfoxyde, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Diméthylsulfoxyde, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Diméthylsulfoxyde, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Diméthylsulfoxyde, anhydrous, ≥99.9%
Sigma-Aldrich
L-Glutathion réduit, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
Diméthylsulfoxyde, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
L-Glutathion réduit, ≥98.0%
Sigma-Aldrich
Diméthylsulfoxyde, PCR Reagent
Sigma-Aldrich
Diméthylsulfoxyde, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Phenol Red, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
tert-Butyl acetoacetate, reagent grade, 98%
Supelco
L-Glutathion réduit, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Dansylcadaverine, ≥97% (TLC)
Sigma-Aldrich
Phenol Red, ACS reagent
USP
Diméthylsulfoxyde, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dansylcadaverine, suitable for fluorescence, BioReagent, ≥99.0% (HPLC)
Sigma-Aldrich
L-Glutathion réduit, BioXtra, ≥98.0%
Supelco
Diméthylsulfoxyde, analytical standard
Supelco
Diméthylsulfoxyde, for inorganic trace analysis, ≥99.99995% (metals basis)
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
L-Glutathion réduit, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Thrombopoietin human, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture, ≥98% (SDS-PAGE and HPLC)
Diméthylsulfoxyde, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human RAPGEF1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Rapgef1